Product Information

HYDROXYZINE PAM 100 MG CAP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.4449 per EA under NDC 00555032402. Its NADAC has been published 657 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the Hydroxyzine Pamoate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

HYDROXYZINE PAM 100 MG CAP

Hydroxyzine Pamoate
$0.4449per EA
High Outlier

Strength

100 mg/1

NDC

00555032402

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

HYDROXYZINE PAMOATE

Approval Type

Generic (ANDA)

FDA Application

ANDA088488

On Market Since

7/1/1984

Pharmacological Classes

Antihistamine
Histamine Receptor Antagonists

Price Statistics

The NADAC for HYDROXYZINE PAM 100 MG CAP has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 78.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4449 per EA
All-time high$0.5397 (Sep 14, 2016)
All-time low$0.2375 (Apr 23, 2014)
52-week high$0.4449
52-week low$0.4057
Median price$0.4223
Average price$0.4163
Largest weekly change+59.9% (Jun 18, 2014)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.4%

3M

+0.6%

6M

+7.6%

1Y

+5.8%

3Y

+6.7%

5Y

+0.6%

All

+78.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Hydroxyzine Pamoate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of HYDROXYZINE PAM 100 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE PAM 100 MG CAP, manufactured by Teva Pharmaceuticals USA Inc., is $0.4449 per EA (NDC 00555032402), effective Jun 24, 2026.

How has the price of HYDROXYZINE PAM 100 MG CAP changed over time?

Over the history we have for it, the NADAC for HYDROXYZINE PAM 100 MG CAP has risen 78.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for HYDROXYZINE PAM 100 MG CAP?

Since Nov 28, 2013, the NADAC for HYDROXYZINE PAM 100 MG CAP has ranged from a low of $0.2375 (Apr 23, 2014) to a high of $0.5397 (Sep 14, 2016), with a median of $0.4223 per EA.

Are there cheaper alternatives to HYDROXYZINE PAM 100 MG CAP?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of HYDROXYZINE PAM 100 MG CAP, so no direct lower-cost alternative is listed.

Who manufactures HYDROXYZINE PAM 100 MG CAP?

HYDROXYZINE PAM 100 MG CAP (NDC 00555032402) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.